Results 211 to 220 of about 4,834,992 (345)

Development of a robotic training curriculum for visceral and gastrointestinal surgical trainees: an international Delphi study. [PDF]

Surg Endosc
Fadel MG, Walshaw J, Yiasemidou M, Boal M, Pecchini F, Elhadi M, Massey LH, Carrano FM, Fehervari M, Walsh CM, Boshier PR, Eckhoff J, Buckle P, ERSC Study Group, Gisbertz SS, Bouvy N, Arezzo A, Perretta S, Nickel F, Khan J, Hanna GB, Seeliger B, Antoniou SA, Fuchs HF, Francis NK, Kontovounisios C.   +25 more
europepmc   +3 more sources

Outcomes of avoidance of routine nasogastric decompression following elective major gastrointestinal and hepatopancreatobiliary surgery: a single-center prospective observational cohort study. [PDF]

Ann Med Surg (Lond)
Parshaila R, Agarwal N, Dangi T, Yadav D, Nalbo D, Shrestha BC, Pandit N.   +6 more
europepmc   +1 more source

Inorganic Nanomaterials can Promote or Inhibit Tumor Metastasis Depending on Tumor Microenvironment Composition

Advanced Science, EarlyView.
As engineered nanomaterials gain prominence in cancer imaging and therapy, understanding their impact on tumor progression becomes increasingly critical. We demonstrate that gold and silica‐coated gold nanomaterials can either suppress or enhance breast cancer metastasis through distinct tumor microenvironment interactions, while identifying ...
Kiana Buttiens, Xiaoqi Zheng, Xueqi Fan, Mukaddes Izci, Christy Maksoudian, Irati Perez Gilabert, Tianjiao Chu, Filipa Goncalves, Jonas Dehairs, Johan Swinnen, Bella B. Manshian, Stefaan J. Soenen   +11 more
wiley   +1 more source

Glucagon-like Peptide-1 Receptor Agonists and the Perioperative Patient. [PDF]

AORN J
Fischer L.
europepmc   +1 more source

Targeting the PHB2–ACSL3 Lipid‐Remodeling Axis Overcomes Cisplatin Resistance by Restoring Ferroptosis in Gastric Cancer

Advanced Science, EarlyView.
ABSTRACT Platinum‐based chemotherapy resistance remains a major obstacle in gastric cancer (GC) treatment. Through integrated transcriptomic profiling of cisplatin‐resistant xenografts and pharmacogenomic interrogation of the NCI‐60 dataset, we identified Prohibitin‐2 (PHB2) as a previously unrecognized determinant of chemoresistance.
Liang Xu, Wanying Xiang, Xinyue Wang, Yue Pan, Jing Gao, Jiezhen Yang, Yufei Wang, Zhipu Zhu, Man Tong, Lei Jin, Yan Ye   +10 more
wiley   +1 more source

Structured surveillance in Lynch syndrome: effectiveness, limitations, and unmet needs. [PDF]

ESMO Gastrointest Oncol
Dardenne A, Cohen R, Evrevin C, Duros C, Basset N, Cervera P, Lefevre JH, Germain T, Lepillier C, Chabbert-Buffet N, André T, Dray X, Parc Y.   +12 more
europepmc   +1 more source

Abstract Journal for Upper GI Surgery [PDF]

ANZ Journal of Surgery, 2016
openaire   +1 more source

Tissue‐Agnostic Cellular Morphometric Biomarkers for Risk‐Adapted Management Across Gastrointestinal Precancerous Lesions and Cancers

Advanced Science, EarlyView.
An interpretable, unsupervised artificial intelligence framework identifies a 13‐cellular morphometric biomarker (CMB) signature from routine H&E whole‐slide images. Validated across 2,602 patients, the fixed signature generalizes across colorectal, gastric, and esophageal tissues without retraining, stratifies prognosis and precancerous lesion risk ...
Pin Wang, Chengfei Jiang, April W. Mao, Qi Sun, Yijun Lu, Jingjing Wei, Jamie L. Inman, Susan E. Celniker, Antoine M. Snijders, David W. Threadgill, Allan Balmain, Bo Hang, Hang Chang, Lei Wang, Jian‐Hua Mao   +14 more
wiley   +1 more source

Discovery and management of arteriovenous malformation with jejunal diverticulum: elusive gastrointestinal bleed. [PDF]

J Surg Case Rep
Panayides A, Tremis ME, Lu C, Parker GS.
europepmc   +1 more source

[GI bleeding. Surgery in GI bleeding].

Revista de gastroenterologia de Mexico, 2015
openaire   +1 more source